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In the past decades, the progress made in plant biotechnology has made possible the use of plants as a novel
production platform for a wide range of molecules. In this context, the transformation of the plastid genome
has given a huge boost to prove that plants are a promising system to produce recombinant proteins. In this
review, we provide a background on plastid genetics and on the principles of this technology in higher plants.
Further, we discuss the most recent biotechnological applications of plastid transformation for the production
of enzymes, therapeutic proteins, antibiotics, and proteins with immunological properties. We also discuss
the potential of plastid biotechnology and the novel tools developed to overcome some limitations of
chloroplast transformation.
© 2011 Elsevier Inc. All rights reserved.
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1. Introduction
A rangeof expression systemshas beenproposed for theproductionof
recombinant proteins with pharmaceutical, industrial and agricultural
interest (Demain and Vaishnav, 2009). The bacterium Escherichia coli
among prokaryotes and the Chinese Hamster Ovary (CHO) cells and
yeasts (Saccharomyces cerevisiae, Pichia pastoris and others) among
eukaryotes have the longest history of use and represent 39, 35 and
15%, respectively, of biopharmaceuticals produced (Rader, 2008). Addi-
tional systems include other bacteria (e.g. Bacillus spp.), ﬁlamentous fungi
(Aspergillus spp., etc.), insect cells (mainly from the Lepidoptera
Spodoptera frugiperda), other mammalian cells, protozoa (Leishmania
spp. and others), transgenic animals, microalgae, and plants. Both stable
and transient transgene expression systems have been developed in
mammalian cells. Advantages anddisadvantages of different systems, and
relevant factors forproteinyieldandgeneral efﬁciency,havebeenrecently
reviewed (Demain and Vaishnav, 2009; Fernandez-Robledo and Vasta,
2010; Hacker et al., 2009; Houdebine, 2009; Potvin and Zhang, 2010;
Surzycki et al., 2009).
Higher plants have been proposed as an economic, safe and easily
scalable production system. Plants are eukaryotic organisms and so they
can produce complex proteins and process them post-translationally
similarly, except for some differences in the glycosylation pattern, to
animals. In addition, they are considered GRAS (“Generally Recognized
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As Safe”) organisms and can be exploited for oral and mucosal delivery
of vaccines and other biopharmaceuticals (Demain and Vaishnav, 2009;
Karg and Kallio, 2009; Mett et al., 2008; Rybicki, 2009; Sharma and
Sharma, 2009; Tiwari et al., 2009;YusibovandRabindran, 2008).Usinga
range of biological and physical methods, plants can be transformed
stably, inserting transgenes either in the nuclear or the plastid genome,
or transiently. While in case of plastid transformation proteins are
synthesized and accumulated in the same organelles, those derived
from nuclear genes are synthesized in the cytoplasm, but they can be
also secreted or directed to various sub-cellular compartments using
appropriate signal peptides. On the other hand, using appropriate
promoter sequences, it is possible to express the transgene in different
plant organs, usually leaves or seeds. The choice of the plant organ and
sub-cellular compartment, as well as the host plant species, depends on
the recombinant protein to be expressed, but it can be of paramount
importance for the accumulation level eventually obtained (Daniell et
al., 2009b; Karg and Kallio, 2009; Lau and Sun, 2009; Rao et al., 2009;
Sharma and Sharma, 2009; Tiwari et al., 2009). Besides whole plants
grown in openﬁeld or greenhouses, cell suspensions, hairy root cultures
and aquatic plants grown in bioreactors have been developed for better
containment of the recombinant product (Franconi et al., 2010; Huang
and McDonald, 2009; Ono and Tian, 2011; Shih and Doran, 2009; Xu et
al., 2011). The biocontainment of transgenes and the level and stability
of protein yield are the main concerns related to the use of plants as
biofactories. Hence, both aspects have been deeply investigated and
several strategies to improve them have been developed (Desai et al.,
2010; Jamal et al., 2009; Murphy, 2007; Streatﬁeld, 2007).
In this review, we focus on plastid transformation in higher plants
as a recombinant protein production platform for different purposes.
Compared to nuclear transformation, the main advantages of this
technology are the high and stable production level of proteins as well
as the natural containment of transgenes (Meyers et al., 2010). Since
the pioneering work of Svab and colleagues in tobacco (Svab et al.,
1990; Svab and Maliga, 1993), the technology has been extended to
several other species and used for a wide range of objectives (Maliga
and Bock, 2011). Herein, we give some background information on
the technology and we discuss its potential and limitations. However,
due to space constraints and to the availability of recent reviews (e.g.
Bock, 2007a; Bock and Warzecha, 2010; Cardi et al., 2010; Daniell et
al., 2009b; Hasunuma et al., 2009; Maliga and Bock, 2011), we limited
our search of recombinant proteins produced in transgenic plastids to
the last three years.
2. Plastids and plastid genomes
Morphology and function of higher plant plastids vary in different
plant tissues, e.g. green chloroplasts are present in photosynthetically
active cells, red/orange/yellow chromoplasts in fruits and ﬂowers,
colorless plastids in storage organs (Pyke, 2007). All plastid types
derive from a small and unpigmented organelle named ‘proplastid’
and present in meristematic cells.
The plastid genome (ptDNA or plastome) is usually represented as
a circular molecule of double-stranded DNA, with a size range of 120–
160 kb in higher plants. Most plastomes show a tetrapartite genome
organization with a large single copy region (LSC) and a small single
copy region (SSC) separated by two inverted repeat regions (IRs) that
differ only in their relative orientation (Fig. 1).
Plastids have an endosymbiotic origin. Compared to their cyano-
bacterial ancestors, they retain only a small portion of genes (110–120)
which can be classiﬁed in three major groups: protein synthesis genes
(encoding for rRNAs, RNA polymerase subunits, tRNAs, ribosomal
proteins), photosynthesis-related genes (encoding for subunits of
enzymatic protein complexes and other proteins involved in photosyn-
thetic reactions), and other genes (genes with other functions,
conserved and other open reading frames). Despite its small size,
ptDNA represents a signiﬁcant fraction of total cellular DNA (about 10–
20%) due to its presence in high copy numbers; it has been estimated
that, depending on species, tissue, developmental stage and environ-
mental conditions, a plant cell can carry up to 10,000 identical copies of
ptDNA (Bock, 2007b).
Besides several prokaryotic features, plastids acquired novel
characters that make the regulation of gene expression rather
complex. In fact, plastid gene expression is controlled at several
transcriptional and post-transcriptional steps (Eberhard et al., 2002;
Kahlau and Bock, 2008; Schmitz-Linneweber and Small, 2008; Valkov
et al., 2009).
Transcription of plastid genes is carried out by three different RNA
polymerases: RPOTp and RPOTmp have a sub-cellular localization only
in plastids (p) or in plastids and mitochondria (mp), are monomeric,
nuclear-encoded (NEP) and are homologous to the phage-type RNA
polymerase. On the other hand, the plastid-encoded polymerase (PEP)
is a multi-subunit enzyme, highly homologous to the eubacterial RNA
polymerase (Lerbs-Mache, 2011). Although several studies demon-
strated that NEP and PEP enzymes preferentially transcribe plastid
genes encodingproteins involved ingeneexpressionor photosynthesis-
related genes, respectively, it has been shown that some genes contain
promoters for both polymerases (for reviews see Lerbs-Mache, 2011;
Liere and Börner, 2007). Post-transcriptional mechanisms, such as RNA
processing and editing, are also important steps to regulate plastid gene
expression (Bollenbach et al., 2007; Schmitz-Linneweber and Barkan,
2007).
Plastid translation shares various features with that of eubacteria,
like initiation factors, rRNAs, tRNAs and 70S-type ribosomes, and its
regulation is mainly controlled by the initiation phase through an
interaction of sequence elements in the 5′-untranslated region (5′-UTR)
of themRNA and nuclear encoded translation factors (Marín-Navarro et
al., 2007; Peled-Zehavi and Danon, 2007). Further, the ribosome
recruitment to the mRNA is often mediated by ribosome-binding sites
(also known as Shine-Dalgarno sequences), which display sequence
complementarity to the 3′-end of the 16S ribosomal RNA (Kozak, 2005).
Nevertheless, in tobacco chloroplasts, 30 of the 79 protein-coding genes
donot contain a SD-like sequence, suggesting an alternativemechanism
involving other cis-elements and trans-acting factors for correct
translation initiation (Sugiura et al., 1998).
Major levels of post-translational regulation in plastid gene
expression are protein degradation and stability. Biochemical and
genetic studies identiﬁed several proteases that have two types of
function: an endopeptidic activity, essential for maturation of most
plastidial proteins post-translationally targeted to the organelle; and a
gradual degradation of unnecessary and likely non-functional pro-
teins (for review see Sakamoto, 2006). A very recent study identiﬁed
protein stability determinants in vivo by producing transplastomic
plants expressing the GFP protein with N- and C-termini modiﬁed.
The authors proposed that the stability of plastid proteins is
inﬂuenced by three factors: the action of methionine aminopeptidase
involved in the removal of the initiator methionine, whose efﬁciency
varies with sequence context; N-end-rule-like protein degradation
pathway in which protein stability is dependent on the identity of the
penultimate amino acid; and additional sequences in the N-terminal
region (Apel et al., 2010). Understanding protein stability determi-
nants in chloroplasts is important to increment the accumulation
levels of recombinant proteins obtainable in transgenic plastids and is
therefore pivotal for plastid transformation technology.
3. Plastid transformation
In the last few years, plastid transformation has opened new
perspectives to plant biotechnologists for using plants as a protein
production platform, due to several advantages offered by transplas-
tomic plants compared to conventional transgenic plants (Bock and
Warzecha, 2010; Cardi et al., 2010; Daniell et al., 2005; Maliga, 2002).
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Unlike nuclear transformation, transgene integration into the
plastome is based on two homologous recombination events between
the targeting regions of the transformation vector and the wild-type
ptDNA (Fig. 2). Recently, it has been demonstrated that the extent of
similarity between the plastidial sequences involved in homologous
recombination is important to ensure high transformation efﬁciency
(Ruhlman et al., 2010; Valkov et al., 2011).
Transformation vectors derive from E. coli plasmids and, besides
the two plastid sequences involved in recombination (ﬂanking
sequences A and B in Fig. 2), include the selectable marker gene
(smg) and the gene of interest (goi) expression cassettes. To date,
several plastid sequences have been used as transgene insertion sites
(Maliga, 2004), even if three of them are themost employed in plastid
transformation vectors: the trnV-3′/rps12 and trnI/trnA regions
located in the IRs (Daniell et al., 1998; Zoubenko et al., 1994), and
the trnfM/trnG region in the LSC (Ruf et al., 2001).
The chimeric aadA gene, that confers resistance to spectinomycin
and streptomycin, is the most common selectable marker included in
transformation vectors. Kanamycin-resistance genes (neo and aphA-6,
Carrer et al., 1993; Huang et al., 2002) and, more recently, genes
conferring resistance to 4-methylindole and 7-methyl-DL-tryptophan
(asa2, Barone et al., 2009) and chloramphenicol (cat, Li et al., 2011)
have been also successfully employed as selective agents.
The expression cassettes usually consist of a 5′-regulatory region,
which includes a strong promoter (P) and a translational control region
(L, leader), and a 3′-regulatory region, composed of a terminator
Fig. 1. Physical map, produced by OrganellarGenomeDRAWweb-tool (Lohse et al., 2007), of the Solanum tuberosum (potato) plastid genome (Gargano et al., 2005) as an example of
higher plant plastomes. Genes inside the circle are transcribed clockwise, whereas those outside the circle are transcribed counterclockwise. LSC=Large Single Copy region;
SSC=Small Single Copy region; IRA and IRB=Inverted Repeat regions A and B, respectively.
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sequence (T) which corresponds to the mRNA 3′-untranslated region
(3′-UTR) (Fig. 2). The leader sequencesmay contain either a 5′-UTR or a
5′-UTR and the N-terminus of the coding region (5′-TCR) (Maliga,
2002). In some cases, the use of a 5′-TCR was found to be essential to
ensure protein production (Lenzi et al., 2008) or to obtain a notable
increase in protein yield (Maliga, 2002; Scotti et al., 2009).
The transforming DNA can be delivered into the plastome either by
the biolistic approach or the polyethylene glycol (PEG) treatment of
protoplasts (Cardi et al., 2010). The ﬁrst method is the system of
choice in several laboratories due to its simplicity and the lack of an
efﬁcient shoot regeneration protocol from protoplasts in many crop
species. Due to the polyploid nature of plastids, the primary
regenerants are usually in a heteroplasmic state containing a mixed
population of wild-type and transformed plastomes and plastids
(Fig. 3A). Indeed, the homoplasmic state, with a homogeneous
population of transformed plastids, is achieved after a sufﬁcient
number of cell divisions under high selective pressure (Fig. 3B). The
identiﬁcation of homoplasmic plants is usually carried out by PCR or
Southern analyses (Fig. 3C); subsequently, molecular analyses are
accomplished on these plants to evaluate gene expression (Fig. 3D).
More recently, a visual marker gene (aadAau) that allows both
selection and detection of transplastomic sectors by leaf color has
been developed in tobacco (Tungsuchat-Huang et al., 2011).
4. Applications of plastid transformation
Due to the high expression levels of recombinant proteins that can
be attained, the plastid transformation technology is particularly
suitable for the use of plants as biofactories. Hence, many proteins
with pharmaceutical interest have been produced in transplastomic
plants in the last three years (Tables 1 and 2). Several recombinant
enzymes have been also expressed in transgenic plastids (Table 3).
Finally, plastid transformation has been used for efﬁcient metabolic
engineering of several pathways located in this organelle as well as for
the production of antimetabolites conferring insect resistance to
plants (Table 3).
4.1. Therapeutic proteins and antibiotics
Recently, Lim et al. (2011) described the production of the human
thioredoxin 1 in transplastomic lettuce and characterized the biologically
active protein that reduced insulin disulﬁdes. Boyhan and Daniell (2011)
have expressed in tobacco and lettuce chloroplasts the cholera toxin B
subunit (CTB) fused with the complete human proinsulin (A, B, C
Fig. 2. Schematic representation of transgene sequence integration in a plastid genome
through two homologous recombination events between the plastid ﬂanking
sequences in the vector (Flanking sequences A and B) and the corresponding sequences
in the wild-type ptDNA (Wt ptDNA). P=promoter; L=leader; T=terminator;
smg=selectable marker gene; goi=gene of interest; and T ptDNA=transformed
ptDNA. Unmarked boxes in the Wt and T ptDNA represent additional genes not
involved in transformation.
Fig. 3. Examples of regeneration of transplastomic plants and molecular analyses. A) Regeneration of a heteroplasmic shoot on selective medium. B) Regeneration of a homoplasmic
shoot on selective medium. C) Southern and PCR analyses to identify homoplasmic plants. D) Northern analysis to show the accumulation of mono- or dicistronic transcripts.
Wt=wild-type plants; He=heteroplasmic plants; Ho=homoplasmic plants; T plants “A”=transformed plants “A”; T plants “B”=transformed plants “B”; goi=monocistronic
transcript; and goi/smg=dicistronic transcript.
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peptides). The fusion of proinsulin to CTB should protect the N-terminus
of insulin fromdegradation, provide ameans to facilitate puriﬁcation and
facilitate the uptake of orally delivered insulin into the gut-associated
lymphoid tissue (GALT). Oral or injectable delivery of the transplastomic
materials into mice showed reduction in blood glucose levels similar to
commercial insulin (Table 1). In addition, Verma et al. (2010b) expressed
in plastids CTB fused with the coagulation factor IX (CTB-F.IX) to aid in
treatment of hemophilia B. After oral administration, F.IX was found in
different tissues of the GALT, speciﬁcally the ileum, Peyer's patches, liver
and plasma within 2–5 h.
An alternative strategy was followed for the production in plastids
of the therapeutic protein aprotinin, a bovine serine protease
inhibitor, that contains an arginine N-terminal residue and whose
structure depends on the correct formation and pairing of three
disulphide bonds (Tissot et al., 2008). The recombinant protein was
targeted to the lumen of thylakoids using signal peptides derived from
Arabidopsis nuclear genes that encode luminal proteins. Translocation
of aprotinin into the thylakoid lumen was attempted using two
different secretion pathways: the general secretion (Sec) and the
twin-arginine translocation (Tat) pathways. In both cases, the plant-
made aprotinin was secreted within the lumen of thylakoids and was
produced with its N-terminal arginine residue. The recombinant
plastid-made protein had an active conformation able to bind trypsin,
suggesting the formation and pairing of the three disulphide bonds
(Tissot et al., 2008). More recently, Daniell et al. (2009a) expressed the
native and the optimized synthetic IGF-1 (Insulin like Growth Factor-1)
genes in E. coli and in transplastomic plants. Expression of both genes
was obtained only in transgenic tobacco plant lines where the
expression of IGF-1 reached up to 32% Total Soluble Protein (TSP)
using plastid light regulatory elements and under continuous
Table 1
Overview of the therapeutic proteins and antibiotics recently produced in plant chloroplasts (2008–2011).
Protein Source of transgene Plant species Protein yield Protein functionality References
CTB-proinsulin Human Tobaacco 47% TLP Veriﬁed Boyhan and Daniell, 2011
Lettuce 53% TLP Veriﬁed
Insulin like growth factor-1a, b Human Tobacco 32.7% TSPa Veriﬁed Daniell et al., 2009a
32.4% TSPb
Cardiotrophin-1 Human Tobacco 4.8% TSP Veriﬁed Farran et al., 2008
Aprotinina Bovine Tobacco 0.5% TSP Veriﬁed Tissot et al., 2008
Alpha1-antitrypsina Human Tobacco 2% TSP Veriﬁed Nadai et al., 2009
CTB-F.IX (Coagulation factor IX) Human Tobacco 3.8% TSP Veriﬁed Verma et al., 2010b
Thioredoxin 1 Human Lettuce 1% TSP Veriﬁed Lim et al., 2011
Retrocyclin-101-GFP Human Tobacco 38% TSP Veriﬁed Lee et al., 2011
Protegrin-1-GFP Porcine Tobacco 26% TSP Veriﬁed Lee et al., 2011
Endolysin Cpl-1a Phage infecting Streptococcus pneumoniae Tobacco 10% TSP Veriﬁed Oey et al., 2009b
Endolysin Pala Phage infecting S. pneumoniae Tobacco 30% TSP Veriﬁed Oey et al., 2009b
Endolysin PlyGBSa Phage infecting S. agalactiae Tobacco 70% TSP Veriﬁed Oey et al., 2009a
a Synthetic genes with plastid-optimized codon usage.
b Native insulin like growth factor 1 gene.
Table 2
Overview of the proteins with immunological properties recently produced in plant chloroplasts (2008–2011).
Protein Source of transgene Plant species Protein
level
Protein immunogenicity References
p24-Nefa HIV-1 Tobacco 40% TSP NRb Zhou et al., 2008
Tomato 2.5% TSP NR
Pr55gag HIV-1 Tobacco 7–8% TSP NR Scotti et al., 2009
p24a HIV-1 Tobacco (Maryland
Mammoth)
4.5% TSP NR McCabe et al., 2008
L1_2xCysM
(Mutated L1)
HPV-16 Tobacco 1.5% TSP NR Waheed et al., 2011
L1a HPV-16 Tobacco 1.5% TSP NR Lenzi et al., 2008
L1 HPV-16 Tobacco 24% TSP Immunogenic in mice Fernández-San Millán et al.,
2008
E7-CP HPV-16 Tobacco 0.5% TSP NR Morgenfeld et al., 2009
A27L Vaccinia virus Tobacco 18% TSP NR Rigano et al., 2009
F1-V Yersinia pestis Tobacco 14.8% TSP Immunogenic in mice Arlen et al., 2008
VP-βGUS Footh-and-mouth disease virus Tobacco 51% TSP Immunogenic in Mice Lentz et al., 2010
E2 Classical swine fever virus Tobacco 1–2% TSP Immunogenic in mice Shao et al., 2008
2 L21-TD Canine parvovirus Tobacco 6% TSP Immunogenic in mice Ortigosa et al., 2010
DPT Corynebacterium Diphtheria,
Bordetella pertussis, Clostridium tetani
Tobacco 0.8% TSP Immunogenic in mice Soria-Guerra et al., 2009
CTB-AMA1 Vibrio cholerae-Plasmodium
falciparum
Tobacco 13.2% TSP Immunogenic in mice Davoodi-Semiromi et al., 2010
Lettuce 7.3% TSP
CTB-MSP1 V. cholerae-P. falciparum Tobacco 10.1% TSP Immunogenic in mice Davoodi-Semiromi et al., 2010
Lettuce 6.1% TSP
LTB-STa Escherichia coli Tobacco 2.3% TSP Immunogenic in mice Rosales-Mendoza et al., 2009
LTB-HNEa Newcastle disease virus Tobacco 0.5%TSP NR Sim et al., 2009
Adjuvant
EDA (Extra domain
A-ﬁbronectin)
Mouse Tobacco 2% TCP Retain proinﬂammatory
properties
Farran et al., 2010
a Synthetic genes with plastid-optimized codon usage.
b Not reported.
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illumination (Daniell et al., 2009a). In the same year, Nadai et al. (2009)
reported the expression of the human alpha1-antitrypsin, a serine-
protease inhibitor, in transgenic chloroplasts. The plastid-made thera-
peuticproteinwas fully active andwasable tobind toporcinepancreatic
elastase (Nadai et al., 2009).
Plastid transformationhas been recentlyused alsoas a novel strategy
for large-scale, cost-effective production of next-generation antibiotics
for topical and systemic treatments (Lee et al., 2011;Oey et al., 2009a, b).
Two recent studies from the same laboratory group explored the
feasibility of producing endolysin-type protein antibiotics in transgenic
tobacco chloroplasts (Oey et al., 2009a,b). Expression of two genes
encoding phage endolysin proteins was tested in tobacco plastids using
a new strategy (called toxin shuttle) that allows the production in
transgenic chloroplasts of proteins that are toxic to E. coli (Oey et al.,
2009b). Expression cassettes that confer high-level protein expression
in plastids usually drive high-level protein expression also in bacterial
cloning hosts; therefore, cloning of genes encoding for proteins with
antibacterial activities can be problematic. The toxin shuttle strategy
developed in the latter study was based on preventing lethal transgene
transcription in E. coli by inducing premature transcription termination
upstream of the transgene coding region using bacterial transcription
terminators. The bacterial terminators were ﬂanked by loxP sites and
can therefore be excised in planta by site-speciﬁc recombination after
chloroplast transformation. Using the toxin shuttle strategy, Oey et al.
(2009b) produced two lysine-type protein antibiotics (Cpl-1 and Pal)
against Streptococcus pneumoniae. The 2 phage-derived protein antibi-
otics, that proved to be unclonable into standard plastid expression
cassettes, accumulated at high-level (up to 30% TSP) in transgenic
plastids and efﬁciently killed pathogenic strains of S. pneumoniae. In the
same year, the same research group described the production of the
lysine PlyGBS in tobacco chloroplasts. Expression levels of the synthetic
plyGBS gene in chloroplasts were so high (more than 70% TSP, the
highest foreign protein accumulation level ever obtained in a transgenic
plant) that the production of endogenous chloroplast proteins was
severely compromised. The authors speculated that this was due to the
fact that massive production of the recombinant protein exhausted the
plastid gene expression capacity. The plastid-made PlyGBS protein
antibioticwashighly active and efﬁciently killed a pathogenic strain of S.
pyogenes (Oey et al., 2009a).
Lee et al. (2011) investigated the expression of two potent
disulphide-bonded antimicrobial peptides in transgenic tobacco plastids:
Retrocyclin-101 (RC101) and Protegrin-1 (PG1). To facilitate expression,
detection andquantiﬁcation of thepeptidesRC101 andPG1, eachpeptide
was expressed in transgenic plastids fused with GFP. The antibacterial
Table 3
Overview of the enzymes recently produced in plant chloroplasts (2008–2011).
Enzyme Source of transgene Plant
species
Protein yield Enzyme activity References
Lycopene β-cyclase Erwinia herbicola Tomato NRa Low Apel and Bock, 2009
Lycopene β-cyclase Narcissus pseudonarcissus Tomato NR 1 mg β-carotene/g DW Apel and Bock, 2009
Endoglucanase Clostridium thermocellum Tobacco NR 493 U/mg in crude TSP Verma et al., 2010a
Exoglucanase C. thermocellum Tobacco NR 442 U/mg in crude TSP Verma et al., 2010a
Lipase Mycobacterium tuberculosis Tobacco NR Detected Verma et al., 2010a
Pectate lyase A Fusarium solani Tobacco NR 2.81 U/mg in crude TSP Verma et al., 2010a
Pectate lyase B F. solani Tobacco NR 2.42 U/mg in crude TSP Verma et al., 2010a
Pectate lyase D F. solani Tobacco NR 2.31 U/mg in crude TSP Verma et al., 2010a
Cutinase F. solani Tobacco NR 15 U/mg in crude TSP Verma et al., 2010a
Endoglucanase Trichoderma reesei Tobacco NR 339 U/mg in crude TSP Verma et al., 2010a
Swollenin T. reesei Tobacco NR Detected Verma et al., 2010a
Xylanase T. reesei Tobacco NR 421 U/mg in crude TSP Verma et al., 2010a
Acetyl xylan esterase T. reesei Tobacco NR Detected Verma et al., 2010a
Beta glucosidase T. reesei Tobacco NR 14 U/mg in crude TSP Verma et al., 2010a
GH10 xylanase Xyl10B Thermotoga maritima Tobacco 13% TSP 22.9–61.9 U/g DW Kim et al., 2011
Endo-β-1,4-glucanase
E1 catalytic domain
Acidothermus celluloyticus Tobacco 12% TSP (based on enzymatic activity) Ziegelhoffer et al., 2009
Endoglucanase Cel6A Thermobiﬁda fusca Tobacco 10.7% TSP Detected Gray et al., 2009
1-Deoxy-D-xylulose
reductoisomerase
Synechosystis sp. Strain PCC6803 Tobacco 7.4% total stroma
protein
3.5 U/mg protein Hasunuma et al., 2008b
Δ9 desaturase Solanum commersonii and Anacystis
nidulans
Tobacco NR Detected Craig et al., 2008
Tobacco
Choline monooxygenase Beta vulgaris Tobacco NR 250 nmol GlyBet/g FW Zhang et al., 2008
L-aspartate-α-decarboxylase Escherichia coli Tobacco NR 2.3 nmol/mg protein/h (before
stress)
Fouad and Altpeter,
2009
β-carotene ketolase and
β-carotene hydroxylaseb
Brevundimonas sp. SD212 Tobacco NR 5.44 mg/g DW astaxanthin Hasunuma et al., 2008a
β-glucosidase T. reesei Tobacco NR 44.4 U/g fresh leaves Jin et al., 2011
Acetolactate synthase
(mutated)
Arabidopsis thaliana Tobacco NR Detected Shimizu et al., 2008
Chitinase BjCHl1 Brassica juncea Tobacco NR 0028 U/μg/min Guan et al., 2008
Lux operon Photobacterium leiognathi Tobacco NR 82×106 photons/minute Krichevsky et al., 2010
Fructose-1,6/sedoheptulose-1,
7-bisphosphatase
Synechococcus PCC7942 Lettuce 3.5% TSP b7 μmol/min/mg chl. Ichikawa et al., 2010
Endoglucanase Cel9Ac T. fusca Tobacco 40% TSP b30 nmol glucose equivalents Petersen and Bock,
2011
Exoglucanase Cel6Bc T. fusca Tobacco 5% TSP b30 nmol glucose equivalents Petersen and Bock,
2011
β-glucosidase Bgl1C T. fusca Tobacco Between 5 and 40%
TSPc
b200 mU/ml protein sample Petersen and Bock,
2011
Xyloglucanase Xeg74 T. fusca Tobacco Between 5 and 40%
TSPc
b60 nmol glucose equivalents Petersen and Bock,
2011
β-glucosidase BglC T. fusca Tobacco 12% TSP detected Gray et al., 2011
a Not reported.
b Synthetic genes with rape-optimized codon usage.
c Synthetic genes with plastid-optimized codon usage.
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activity of RC101 and PG1 expressed in transplastomic plants was
conﬁrmed by in planta bioassay with Erwinia carotovora. In addition,
RC101 expressed in transgenic plastids conferred resistance to tobacco
mosaic virus infection, conﬁrming RC101 antiviral activity (Lee et al.,
2011).
4.2. Proteins with immunological properties
Plastid-made vaccines proved to be fully functional and able to elicit
the appropriate immune responses in experimental animals and to
protect against toxinor pathogenchallenges. In addition, transplastomic
plants were recently used for the production of adjuvants such as the
vaccine adjuvant extra domain A from ﬁbronectin (Farran et al., 2010).
Two recent reviews (Bock and Warzecha, 2010; Cardi et al., 2010)
describe the production of vaccine antigens in transplastomic plants.
Herein, we will concentrate on the recombinant antigens produced
most recently (Table 2).
Zhou et al. (2008) reported the expression of HIV-1 antigens p24
and Nef in transplastomic tobacco and tomato plants. High antigen
accumulation (up to 40% TSP in tobacco and tomato leaves and 2.5%
TSP in green tomato fruits) was achieved when the p24-nef fusion
gene was inserted in the plastome using an improved plastid
transformation vector designed to prevent rearrangements of
inserted sequences and facilitate selectable marker gene removal.
On the other hand, the fusion protein p24-nef was not detectable in
red ripe fruits, possibly because ripe fruits contain chromoplasts that
are less active in plastid gene expression than chloroplasts (Zhou et
al., 2008). In the same year, McCabe et al. (2008) expressed the
protein p24 in transgenic plastids of Maryland Mammoth, a large
tobacco variety that can produce 1–2 kg of leaf biomass per plant prior
to ﬂowering. Scotti et al. (2009) investigated the possibility of
expressing the HIV structural polyprotein precursor protein Pr55gag
using chloroplast and nuclear transformation. In transplastomic
tobacco plants, the level of expression of Pr55gag was increased up
to 7–8% TSP when the transgene was expressed using a vector with
rbcl 5′-UTR followed by the ﬁrst 42 nucleotides of the plastid
photosynthetic RbcL protein. By comparison, when the protein was
translated in the cytoplasm and imported into the chloroplasts,
recombinant protein levels were between 0.01 and 0.1% TSP,
suggesting that high accumulation levels achieved by plastid
transformation were due to higher synthesis with the latter system
rather than to higher protein stability. The Pr55gag protein produced
in the plastids assembled into spherical particles resembling VLPs
(Virus-Like Particles) produced from baculovirus and E. coli expres-
sion systems.
In the past few years, several studies investigated the feasibility of
producing plant-made vaccines against HPV (human papillomavirus)
based on the major capsid L1 protein that self assembles into
immunogenic capsomeres and VLPs (Table 2). Waheed et al. (2011)
recently described the production of capsomers in transplastomic
plants, since these are considered a cost-saving alternative to VLP-
based HPV vaccines. The authors expressed in tobacco plants a
mutated L1 (L1_2xCysM) gene, which encoded an L1 proteinwith two
cysteines replaced by serines, therefore retaining the ability to
assemble into capsomers. Previously, Lenzi et al. (2008) produced
transplastomic tobacco plants after transformation with several
constructs carrying either the native viral or a plastid-optimized L1
sequence. The highest protein yield (1.5% TSP) was achieved with
vectors that included the 5′-UTR and the ﬁrst 42 nucleotides of the
plastid rbcL gene. ELISA assays and electron microscopy analysis
indicated that the plant-made L1 assembled in higher order
structures. Fernández-San Millán et al. (2008) reported the highest
expression level of L1 protein achieved in transplastomic plants (24%
TSP). Immunization experiments in Balb/c mice demonstrated that
the plastid-derived HPV-16 L1 VLPs were highly immunogenic after
intraperitoneal injection, and neutralizing antibodies were detected.
Recently, Rigano et al. (2009) described the production in tobacco
of the A27L immunogenic protein of vaccinia virus using stable
transformation of the nuclear or plastid genome. In transplastomic
plants, the vaccinia virus protein accumulated to about 18% TSP, a
level of accumulation 500-fold higher than levels obtained in nuclear
transformed plants. The A27L protein was expressed in transplas-
tomic plants in a soluble form and was localized in the stroma. In
addition, the plastid-made protein formed oligomers and was
recognized by serum from a patient previously infected by a zoonotic
orthopoxviruses.
The plastid transformation technology has been used for the
production of peptides expressed as fusions with carrier protein in
order to increase stability andaccumulation levels of the target peptides.
For example, Lentz et al. (2010) described in plantaproduction of a small
immunogenic epitope containing amino acid residues 135–160 of the
structural protein VP1 of FMDV (foot and mouth disease virus) fused
with the β-glucuronidase reporter gene. A very high expression level
(51% TSP) of the FMDV epitope was obtained in transgenic plastids and
the fusion peptide was immunogenic in mice. Following the same
strategy, Ortigosa et al. (2010) produced transplastomic plants carrying
a fusion between the immunogenic peptide 2 L21 derived from the
canine parvovirus VP2 protein and the 42 amino acid tetramerisation
domain (TD) from the human transcription factor p53.
Co-delivery with targeting proteins such as the heat-labile toxin B
subunit from E. coli (LTB) and the cholera toxin B subunit from Vibrio
cholerae (CTB) can also increase the ability of the mucosal immune
system to recognize plant-derived, orally delivered antigens. For
instance, Rosales-Mendoza et al. (2009) reported the production of a
chloroplast-derived vaccine against enterotoxigenic E. coli (ETEC) by
production of a fusion protein comprising LTB and the heat-stable toxin
(ST). The plastid-made LTB-STwas able to bind to the GM1 gangliosides
and elicited protective immune responses against the cholera toxin in
orally immunized mice. In another study, Davoodi-Semiromi et al.
(2010) expressed CTB fused to malarial vaccine antigens apical
membrane antigen-1 (AMA1) and merozoite surface protein-1
(MSP1) in tobacco and lettuce plastids, in order to produce a low-cost
multivalent vaccine. Balb/C mice were immunized both orally with
transplastomic leaves and subcutaneouslywith plastid-derived puriﬁed
antigen. Sera of immunized mice blocked proliferation of the malarial
parasite in red blood cells. In addition, CTB-IgG1 and CTB-IgA in orally
immunized mice and only CTB-IgG1 in subcutaneous immunized mice
conferred immunity against CT challenge. Another multicomponent
vaccine was produced by Soria-Guerra et al. (2009) that expressed a
multi-epitope diphtheria, pertussis and tetanus (DPT) fusion protein in
transplastomic tobacco plants. The sequences of six immunoprotective
exotoxin epitopes of Corynebacterium diphtheriae, Bordetella pertussis
and Clostridium tetani were fused together to form a multiepitope
protein and theDPTgenewas inserted into a plastid expression cassette.
The plastid-made DPT protein induced speciﬁc systemic and mucosal
antibody responses in mice orally immunized with freeze-dried
transplastomic leaves.
4.3. Enzymes and other proteins
Hasunuma et al. (2008a) used plastid transformation to alter
carotenoid compositions and contents in plants (Table 3). The authors
expressed in tobacco plastids two genes encoding for the enzymes β-
carotene ketolase and β-carotene hydroxylase from the marine
bacterium Brevundimonas sp. SD212. In the tobacco transformants,
there was an accumulation in leaves of large quantities of astaxanthin
(up to 5.44 mg g−1 DW, corresponding to more than 70% of the total
carotenoids), while total carotenoid level was 2.1-fold higher than in
wild-type plants. Transplastomic plants synthesized also the novel
carotenoids 4-ketoantheraxanthin and a rare carotenoid fritschiellax-
anthin. In the same year, the same research group used plastid
metabolic engineering tomanipulate the yield of isoprenoids in plants
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by over-expression of the enzyme 1-Deoxy-D-xylulose reductoisome-
rase (DXR) from the cyanobacterium Synechosystis sp. strain PCC6803
(Hasunuma et al., 2008b). More recently, Apel and Bock (2009)
introduced the lycopene β-cyclase genes from the eubacterium
Erwinia herbicola and the plant daffodil (Narcissus pseudonarcissus)
into the tomato plastid genome under the control of the promoter rrn
and the T7g10 5′-UTR in order to increase the contents of the
antioxidant provitamin A. While the expression of the bacterial
enzyme did not strongly alter carotenoid composition, the expression
of the plant enzyme in fruits of transplastomic tomato plants triggered
efﬁcient conversion of lycopene to provitamin A (β-carotene) and led
to a N50% increase in total fruit carotenoid accumulation. In a previous
work, Wurbs and colleagues (2007) expressed the lycopene β-cyclase
genes from E. herbicola and from the zyomycete fungus Phycomyces
blakesleeanus under the control of the promoter atpI in transplastomic
tomatoes. In that case, the fungal gene constructs did not result in
measurable changes of carotenoid biosynthesis while expression of
the bacterial genes resulted in an increase in β-carotene accumula-
tion, but in a lower total carotenoid content than with the plant gene
(Apel and Bock, 2009). Results obtained in the latter studies
demonstrate that the successful application of chloroplast engineer-
ing depends not only on the gene used for metabolic engineering but
also on the origin of the gene and of the expression cassette. A
differential effect was also observed when the dxs gene (encoding the
1-Deoxy-D-xylulose synthase enzyme) was cloned from different
sources and inserted in tobacco chloroplasts. While transplastomic
plants with the sequence from E. coli showed severe alterations in
chloroplast ultrastructure and reduced growth, plants with the same
gene from Synechocystis spp. did not show any detrimental effect
(Scotti et al., unpublished data).
Today, biofuel production from lignocellulosic materials is limited
by the lack of technology, infrastructures and high cost of enzymes.
One interesting option for low-cost production of cellulolytic enzymes
is the use of transplastomic plants. Examples are the expression of an
endoglucanase and a β-glucosidase from Thermobiﬁda fusca and of the
endo-β-1,4-glucanase E1 catalytic domain of Acidothermus celluloyti-
cus in transplastomic tobacco plants (Gray et al., 2009; Gray et al.,
2011; Ziegelhoffer et al., 2009). Recently, Petersen and Bock (2011)
produced in transplastomic plants a set of four thermostable cell wall-
degrading enzymes from the bacterium Thermobiﬁda fusca. Verma et
al. (2010a) used plastid transformation for the expression of the
enzymes endoglucanases, exoglucanase, pectate lysases, cutinase,
swollenin, xylanase, acetyl xylan esterase, beta glusosidase and lipase
from bacteria and fungi and tested the plant-derived enzyme cocktails
for the production of fermentable sugars from lignocellulosic biomass.
Alternatively, Kim and colleagues (2011) expressed the GH10
xylanase Xyl10B from Thermotoga maritima in tobacco chloroplasts
in order to maximize conversion of methylglucuronoxylan, the major
components of hemicellulose in woody biofuel crops, to fermentable
sugars.
Chloroplast transformation has been used also for the improvement
of pest resistance in crop plants (Table 3). For example, the Bacillus
thuringiensis toxin (cry1AB) was expressed in the chloroplasts of
transformed cabbage and conferred high insecticidal efﬁcacy against
Plutella xylostella (Liu et al., 2008). In addition, several studies
investigated new strategies to improve crop yield potential and the
efﬁciency of photosynthesis using plastome transformation for genetic
engineering of the Rubisco, the CO2-ﬁxing enzymewhose large catalytic
subunit is encoded in the plastome (Whitney et al., 2011). A recent paper
described the production of transplastomic lettuce with enhanced
growth and high yield of the chloroplast expressing the cyanobacterial
fructose-1,6/sedoheptulose-1,7-bisphosphatase (FBP/SBPase) in the
chloroplast (Ichikawa et al., 2010). Plastid engineering has been also
conducted to enhance crop tolerance to different abiotic stresses. For
example, the expression of the enzyme choline monooxygenase from
Beta vulgaris in transplastomic tobaccoplants improved salt anddrought
tolerance through accumulation of glycine betaine, a compound that
functions as osmoprotectant in plants (Zhang et al., 2008). In the same
year, Craig et al. (2008) tested the feasibility of using plastid
transformation to engineer lipid metabolic pathways and improve cold
tolerance by production of a Δ9 desaturase gene from either Solanum
commersonii (a wild potato species) or the cyanobacterium Anacystis
nidulans in tobacco plastids. Transplastomic plants showed altered fatty
acid proﬁles and an increase in their unsaturation level both in
vegetative and reproductive tissues. Thework fromCraig and colleagues
(2008) represents the ﬁrst example of transplastomic plants expressing
agronomically relevant genes generated using “binding-type” vectors
based on antibiotic-insensitive point mutations in chloroplast genes.
Transplastomic plants were obtained by PEG-mediated transformation
of leaf protoplasts.
Novel biotechnology applications using plastid transformation
have been recently described by Jin et al. (2011). The authors
expressed a fungal β-glucosidase (Bgl-1) in transplastomic tobacco
plants. Plastid-transformed plants ﬂowered one month earlier and
showed an increase in biomass, height, internode length and leaf area
compared to untransformed plants. In addition, the transplastomic
lines showed an increase in density of leaf globular trichomes that
contain more sugar esters that confer protection from whiteﬂy and
aphid attack. In BGL-1 lines there was an increase in the level of IAA
and trans-Zeatin, and protoplasts from those lines were able to divide
and form calli without exogenous hormones.
Krichevsky and colleagues (2010) demonstrated that even a
complete functional bacterial luciferase pathway of prokaryotes
could be reconstituted in plant plastids. In this study the expression
of the six genes of the lux operon (luxCDABEG) was reported in
transgenic tobacco chloroplasts producing the ﬁrst autoluminescent
plant able to emit light visible by naked eye.
5. Potential and limitations
Since chloroplasts represent a highly polyploidy genetic system,
plastid transformation generally ensures a higher transgene expres-
sion level compared to nuclear transformation. However, the
examples described in the previous sections and in Tables 1–3 clearly
demonstrate that the expression level can be affected by several
factors: protein type, regulatory sequences included in the expression
cassettes, plant tissue, development stage of the plant and protein
stability. The levels of protein accumulation obtainable in transgenic
plastids usually cannot be predicted, even in E. coli cells, which share
similar expressionmechanismswith plastids (Magee et al., 2004), and
some foreign proteins proved to be difﬁcult to express in transplas-
tomic plants (Tables 1–3). For instance, the short peptide 2L21 from
the canine parvovirus VP2 protein did not accumulate in transgenic
plastids and was expressed in transplastomic plants only by fusion
with the p53 tetramerisation domain (Ortigosa et al., 2010). However,
recent studies suggest that some empiric rules can be followed in
order to develop optimized vectors for plastid transformation, such as
the choice of species-speciﬁc plastid sequences for transgene
expression (Ruhlman et al., 2010), or of sequence determinants in
the N-terminal region for protein stability (Apel et al., 2010). Gene
expression in non-green plastids is generally low. Nevertheless,
regulatory sequences potentially useful to increase transgene expres-
sion in tomato chromoplasts and potato amyloplasts have been
identiﬁed (Kahlau and Bock, 2008; Valkov et al., 2009; Valkov et al.,
2011).
Post-translational modiﬁcations, such as disulphide bond forma-
tions, can also inﬂuence the stability of the plastid-made recombinant
proteins and hence inﬂuence protein accumulation (De Marchis et al.,
2011; Tissot et al., 2008). In this regard, it is noteworthy the work of De
Marchis and colleagues (2011). The authors expressed in transplastomic
tobacco plants the fusion protein zeolin (the bean protein phaseolin
fused to the ﬁrst half ofmaizeγ-zein)with its native signal peptide (SP)
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and two mutated forms, one without SP and one without Cys residues
(unable to form disulphide bonds). The signal peptide of phaseolin
targeted zeolin to the thylakoid membranes, where it accumulated as
trimers able to form disulphide bonds, a modiﬁcation that contributed
to protein accumulation.
Several post-translational modiﬁcations can occur in transgenic
plastids, including protein lipidation, multimerization, N-terminal
methionine excision and the already mentioned disulphide bond
formation (De Marchis et al., 2011; Hennig et al., 2007; Rigano et al.,
2009; Tissot et al., 2008). On the other hand, glycosylation is absent in
plastids, preventing the production of glycosylated antigens. The
absence of protein glycosylation could represent a possible limitation
of the plastid transformation technology; however in some cases, for
instance for the production of the therapeutic protein human alpha1-
anti-trypsin (A1AT), the absence of glycosylation could be considered
an advantage (Nadai et al., 2009).
Sometimes, the constitutive high expression level of transgenes can
interfere with plant development, inducing phenotypic alterations and
reduced growth (Rigano et al., 2009; Scotti et al., 2009; Zhou et al.,
2008). For this reason, several approaches to induce transgene
expression in transplastomic plants have been developed (Buhot et
al., 2006; Lössl et al., 2005; Muhlbauer and Koop, 2005; Tungsuchat et
al., 2006; Verhounig et al., 2010). Early systems have been recently
reviewed (Cardi et al., 2010; Khan, 2006; Koop et al., 2007;Wang et al.,
2009). The approach recently proposed by Verhounig and colleagues
(2010) is based on an engineered riboswitch that functions as
translational regulator of transgene expression in transformed plastids
in response to the application of its ligand theophilline. Currently, all
inducible systems described are proof-of-concept experiments devel-
oped in tobacco, the model plant for plastid transformation. Some
optimizations are still needed before the application of these systems to
molecular farming, especially considering the lowprotein yield induced.
An important issue regarding the use of plants as biofactories is
transgene containment, which is one of the main advantages offered
by plastid transformation. In fact, in most crops, plastids are
maternally transmitted to the sexual progeny, and thus pollen does
not contain ptDNA (Cardi et al., 2010). Although this feature ensures
an efﬁcient biocontainment that prevents undesired transgene
transmission to other species, the growth of transplastomic plants
outdoors is still a contentious issue. To address this concern, Michoux
et al. (2011) evaluated the potential of tobacco transplastomic cell
suspensions as a fully contained production system. The authors
produced transplastomic cell suspensions from homoplasmic tobacco
leaves expressing a modiﬁed GFP and the fragment C of tetanus toxin
(TetC), loaded them into a 2-L bioreactor temporally submerged inMS
media supplemented with Thidiazuron to induce shoot formation.
This fully contained biomass production system yielded 660 mg/L
(33% TSP) and 95 mg/L (8% TSP) for GFP and TetC, respectively, values
slightly lower than those obtained with CHO cells.
Another potential advantage of plastid transformation is the
possibility to achieve multigene engineering through expression of
multiple transgenes in prokaryotic-like operons. This feature of
chloroplast transformation allows co-expression of multiple antigens
in plastids for the production of multivalent vaccines against multiple
infectious diseases (Davoodi-Semiromi et al., 2010). In addition, the
possibility of transgene stacking in operons makes chloroplast
transformation an ideal tool for metabolic engineering (Hasunuma
et al., 2009), as demonstrated by the expression in plastids of the
complete bacterial luciferase pathway (luxCDABEG) leading to the
production of a truly autonomously luminescent plant (Krichevsky et
al., 2010).
Presently, besides tobacco, only two plant species have been used
to successfully produce nutraceutical and biopharmaceutical proteins
by plastid transformation: tomato (Apel and Bock, 2009; Wurbs et al.,
2007; Zhou et al., 2008) and lettuce (Davoodi-Semiromi et al., 2010;
Ichikawa et al., 2010; Lim et al., 2011; Ruhlman et al., 2007; Ruhlman
et al., 2010). The development of improved selection/regeneration
protocols and/or transformation vectors containing homologous
ﬂanking sequences increased the transformation efﬁciency in various
plant species other than tobacco (Dufourmantel et al., 2004; Liu et al.,
2007; Ruf et al., 2001; Ruhlman et al., 2010; Valkov et al., 2011; Zubko
et al., 2004). Despite these recent advances, however, the extension of
plastid transformation technology to other crops, especially those
belonging to monocots, is still limited.
6. Conclusions and perspectives
More than 50 different recombinant proteins have been produced in
transgenic plastids in the last three years (Tables 1–3). Although almost
all reports in the literature used tobacco, in the same period there was a
signiﬁcant improvement of the technology in other crop species, now
including important ones such as tomato, petunia, potato, soybean,
lettuce and cabbage (Maliga and Bock, 2011). Considering the recent
scientiﬁc and technological developments in plastid transformation
technology, such as the use of additional marker genes and/or their
removal after selection, the possibility to induce gene expression, the
selection of novel regulatory sequences for expression in chloroplasts
and in non-green plastids (e.g. chromoplasts and amyloplasts) (Maliga
and Bock, 2011), it can be predicted that in the next future the plastid
transformation approachwill be applied to a larger set of species and for
a wider range of purposes. This will allow exploiting the potential
advantages offered by this technology in comparison to nuclear
transformation. The chance of success will depend on the target protein
and thus it will be wise to test several expression cassettes and
transformation vectors in preliminary experiments. Some proteins,
however, will remain not-expressible in transgenic plastids, e.g. those
requiring glycosylation for their functionality.
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